Position in IQV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,444,801
+$5,658,642 QoQ
Shares Held
105,811
+22.0% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
2.12%
of 13F equity value
Holder Rank
#146
of 1,084 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Parkman Healthcare Partners LLC holds $40,995,408 across 5 Diagnostics & Research names. IQV ranks #1 (49.9% of the industry book) .
All Filings in IQV
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,444,801 | 105,811 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,786,159 | 86,702 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,941,194 | 35,230 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,698,200 | 30,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,256,105 | 109,500 | Shares | Sole | 2025-08-14 | |
| 2023-03-31 | $9,077,936 | 45,643 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,149,978 | 15,374 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,370,874 | 35,171 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,614,719 | 39,701 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,581,308 | 50,090 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $20,627,819 | 73,112 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,736,420 | 69,869 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $16,567,176 | 68,369 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $12,756,510 | 66,048 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,431,994 | 58,224 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $8,276,836 | 52,508 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,739,300 | 47,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,235,800 | 30,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||